{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:26:38Z","timestamp":1793042798868,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-026-04366-6","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:07:24Z","timestamp":1776730044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Thermal ablation plus HPV-specific IgY vaginal gel versus watchful waiting in women with histologically confirmed CIN1 and persistent HPV: a prospective observational cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Ming","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salamaiti","family":"Abudurehemu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"3","key":"4366_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4366_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12\u20139. https:\/\/doi.org\/10.1002\/(SICI)1096-9896(199909)189:1%3C12::AID-PATH431%3E3.0.CO;2-F.","journal-title":"J Pathol"},{"issue":"5","key":"4366_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3322\/caac.21628","volume":"70","author":"ETH Fontham","year":"2020","unstructured":"Fontham ETH, Wolf AM, Church TR, Etzioni R, Flowers CR, Herzig A, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin. 2020;70(5):321\u201346. https:\/\/doi.org\/10.3322\/caac.21628.","journal-title":"CA Cancer J Clin"},{"key":"4366_CR4","unstructured":"World Health Organization. WHO recommends DNA testing as a first-choice screening method for cervical cancer prevention. 2021. https:\/\/www.who.int\/europe\/news\/item\/11-09-2021-who-recommends-dna-testing-as-a-first-choice-screening-method-for-cervical-cancer-prevention. Accessed 10 Nov 2025."},{"key":"4366_CR5","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3389\/fonc.2019.00976","volume":"9","author":"C Lazare","year":"2019","unstructured":"Lazare C, Xiao S, Meng Y, Wang C, Li W, Wang Y, et al. Evaluation of cervical intraepithelial neoplasia occurrence following the recorded onset of persistent high-risk human papillomavirus infection: a retrospective study on infection duration. Front Oncol. 2019;9:976. https:\/\/doi.org\/10.3389\/fonc.2019.00976.","journal-title":"Front Oncol"},{"key":"4366_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bpobgyn.2017.08.015","volume":"47","author":"S De Sanjos\u00e9","year":"2018","unstructured":"De Sanjos\u00e9 S, Brotons M, Pav\u00f3n MA. The natural history of human papillomavirus infection. Best Pract Res Clin Obstet Gynaecol. 2018;47:2\u201313. https:\/\/doi.org\/10.1016\/j.bpobgyn.2017.08.015.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"17","key":"4366_CR7","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1093\/jnci\/djg037","volume":"95","author":"NF Schlecht","year":"2003","unstructured":"Schlecht NF, Platt RW, Duarte-Franco E, Costa MC, Sobrinho JP, Prado JC, et al. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst. 2003;95(17):1336\u201343. https:\/\/doi.org\/10.1093\/jnci\/djg037.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"4366_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/LGT.0000000000000604","volume":"25","author":"DL Loopik","year":"2021","unstructured":"Loopik DL, Bentley HA, Eijgenraam MN, IntHout J, Bekkers RL, Bentley JR. The natural history of cervical intraepithelial neoplasia grades 1, 2, and 3: a systematic review and meta-analysis. J Low Genit Tract Dis. 2021;25(3):221\u201331. https:\/\/doi.org\/10.1097\/LGT.0000000000000604.","journal-title":"J Low Genit Tract Dis"},{"issue":"2","key":"4366_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","volume":"24","author":"RB Perkins","year":"2020","unstructured":"Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, et al. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2020;24(2):102\u201331. https:\/\/doi.org\/10.1097\/LGT.0000000000000525.","journal-title":"J Low Genit Tract Dis"},{"key":"4366_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ejogrb.2023.08.369","volume":"290","author":"AE McGee","year":"2023","unstructured":"McGee AE, Alibegashvili T, Elfgren K, Frey B, Grigore M, Heinonen A, et al. European consensus statement on expert colposcopy. Eur J Obstet Gynecol Reprod Biol. 2023;290:27\u201337. https:\/\/doi.org\/10.1016\/j.ejogrb.2023.08.369.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"4366_CR11","doi-asserted-by":"publisher","first-page":"115115","DOI":"10.1016\/j.jviromet.2025.115115","volume":"334","author":"W Chen","year":"2025","unstructured":"Chen W, Xiao H, Lin M, Zhou J, Xuan Q, Cui X, et al. Preparation and evaluation of IgY against human papillomavirus. J Virol Methods. 2025;334:115115. https:\/\/doi.org\/10.1016\/j.jviromet.2025.115115.","journal-title":"J Virol Methods"},{"issue":"10","key":"4366_CR12","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/GME.0000000000001829","volume":"28","author":"M Wang","year":"2021","unstructured":"Wang M, Kartsonaki C, Guo Y, Lv J, Gan W, Chen ZM, et al. Factors related to age at natural menopause in China: results from the China Kadoorie Biobank. Menopause. 2021;28(10):1130\u201342. https:\/\/doi.org\/10.1097\/GME.0000000000001829.","journal-title":"Menopause"},{"key":"4366_CR13","volume-title":"Female genital tumours","author":"WHO Classification of Tumours Editorial Board","year":"2020","unstructured":"WHO Classification of Tumours Editorial Board. Female genital tumours. 5th ed. Lyon: International Agency for Research on Cancer; 2020.","edition":"5"},{"issue":"1","key":"4366_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/ijc.24804","volume":"126","author":"YL Woo","year":"2010","unstructured":"Woo YL, van den Hende M, Sterling JC, Coleman N, Crawford RA, Kwappenberg KM, et al. A prospective study on the natural course of low-grade squamous intraepithelial lesions and the presence of HPV16 E2-, E6- and E7-specific T-cell responses. Int J Cancer. 2010;126(1):133\u201341. https:\/\/doi.org\/10.1002\/ijc.24804.","journal-title":"Int J Cancer"},{"issue":"6","key":"4366_CR15","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1097\/AOG.0b013e318237caf4","volume":"118","author":"PE Castle","year":"2011","unstructured":"Castle PE, Gage JC, Wheeler CM, Schiffman M. The clinical meaning of a cervical intraepithelial neoplasia grade 1 biopsy. Obstet Gynecol. 2011;118(6):1222\u20139. https:\/\/doi.org\/10.1097\/AOG.0b013e318237caf4.","journal-title":"Obstet Gynecol"},{"key":"4366_CR16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ejogrb.2024.09.019","volume":"302","author":"AE McGee","year":"2024","unstructured":"McGee AE, Hawco S, Bhattacharya S, Hanley SJ, Cruickshank ME. Alternatives to surveillance for persistent human papillomavirus after a positive cervical screen: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2024;302:332\u20138. https:\/\/doi.org\/10.1016\/j.ejogrb.2024.09.019.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"4366_CR17","doi-asserted-by":"publisher","first-page":"i3633","DOI":"10.1136\/bmj.i3633","volume":"354","author":"M Kyrgiou","year":"2016","unstructured":"Kyrgiou M, Athanasiou A, Paraskevaidi M, Mitra A, Kalliala I, Martin-Hirsch P, et al. Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis. BMJ. 2016;354:i3633. https:\/\/doi.org\/10.1136\/bmj.i3633.","journal-title":"BMJ"},{"issue":"5","key":"4366_CR18","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.31557\/APJCP.2020.21.5.1391","volume":"21","author":"D Banerjee","year":"2020","unstructured":"Banerjee D, Mandal R, Mandal A, Ghosh I, Mittal S, Muwonge R, et al. A prospective randomized trial to compare safety, acceptability and efficacy of thermal ablation and cryotherapy in a screen and treat setting. Asian Pac J Cancer Prev. 2020;21(5):1391\u20138. https:\/\/doi.org\/10.31557\/APJCP.2020.21.5.1391.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"4366_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/02656736.2020.1749316","volume":"37","author":"Z Fu","year":"2020","unstructured":"Fu Z, Fan Y, Wu C, Yan P, Ye Y, Yang H, et al. Clinical efficacy and mechanism for focused ultrasound (FUS) in the management of cervical intraepithelial neoplasia 1 (CIN1). Int J Hyperth. 2020;37(1):339\u201345. https:\/\/doi.org\/10.1080\/02656736.2020.1749316.","journal-title":"Int J Hyperth"},{"issue":"1","key":"4366_CR20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1080\/02656736.2022.2052365","volume":"39","author":"H Zeng","year":"2022","unstructured":"Zeng H, Liu M, Xiao L, Zhang X, Feng Q, Chang S. Effectiveness and immune responses of focused ultrasound ablation for cervical intraepithelial neoplasia. Int J Hyperth. 2022;39(1):539\u201346. https:\/\/doi.org\/10.1080\/02656736.2022.2052365.","journal-title":"Int J Hyperth"},{"key":"4366_CR21","doi-asserted-by":"publisher","first-page":"102185","DOI":"10.1016\/j.pdpdt.2021.102185","volume":"34","author":"R Ran","year":"2021","unstructured":"Ran R, Wang M, Li X, Liu Q. A prospective study of photodynamic therapy for cervical squamous intraepithelial lesion. Photodiagnosis Photodyn Ther. 2021;34:102185. https:\/\/doi.org\/10.1016\/j.pdpdt.2021.102185.","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"5","key":"4366_CR22","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/ijc.32881","volume":"147","author":"XL Zhao","year":"2020","unstructured":"Zhao XL, Xu XQ, Duan XZ, Rezhake R, Hu SY, Wang Y, et al. Comparative performance evaluation of different HPV tests and triaging strategies using self-samples and feasibility assessment of thermal ablation in \u2018colposcopy and treat\u2019 approach: a population-based study in rural China. Int J Cancer. 2020;147(5):1275\u201385. https:\/\/doi.org\/10.1002\/ijc.32881.","journal-title":"Int J Cancer"},{"key":"4366_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ygyno.2023.09.004","volume":"178","author":"F Chen","year":"2023","unstructured":"Chen F, Zhang GN, Lei W, Zhou SG, Zhang Y, Liu L, et al. Effectiveness and safety of REBACIN as a non-invasive intervention for persistent high-risk human papillomavirus infection: a real-world prospective multicenter cohort study. Gynecol Oncol. 2023;178:8\u201313. https:\/\/doi.org\/10.1016\/j.ygyno.2023.09.004.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"4366_CR24","doi-asserted-by":"publisher","first-page":"8218","DOI":"10.1038\/s41598-025-87568-6","volume":"15","author":"A Abate","year":"2025","unstructured":"Abate A, Munshea A, Nibret E, Alemayehu DH, Alemu A, Abdissa A, et al. Persistence and clearance rates of human papillomaviruses in a cohort of women treated or not treated for cervical dysplasia in northwest Ethiopia. Sci Rep. 2025;15(1):8218. https:\/\/doi.org\/10.1038\/s41598-025-87568-6.","journal-title":"Sci Rep"},{"issue":"1","key":"4366_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1542\/peds.93.1.12","volume":"93","author":"A Guarino","year":"1994","unstructured":"Guarino A, Canani RB, Russo S, Albano F, Rubino A, Canani MB, et al. Oral immunoglobulins for treatment of acute rotaviral gastroenteritis. Pediatrics. 1994;93(1):12\u20136. https:\/\/doi.org\/10.1542\/peds.93.1.12.","journal-title":"Pediatrics"},{"issue":"12","key":"4366_CR26","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/nbt1363","volume":"25","author":"WA Marasco","year":"2007","unstructured":"Marasco WA, Sui J. The growth and potential of human antiviral monoclonal antibody therapeutics. Nat Biotechnol. 2007;25(12):1421\u201334. https:\/\/doi.org\/10.1038\/nbt1363.","journal-title":"Nat Biotechnol"},{"issue":"3\u20134","key":"4366_CR27","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.vetimm.2011.05.003","volume":"142","author":"C Vega","year":"2011","unstructured":"Vega C, Bok M, Chacana P, Saif L, Fernandez F, Parre\u00f1o V. Egg yolk IgY: protection against rotavirus induced diarrhea and modulatory effect on the systemic and mucosal antibody responses in newborn calves. Vet Immunol Immunopathol. 2011;142(3\u20134):156\u201369. https:\/\/doi.org\/10.1016\/j.vetimm.2011.05.003.","journal-title":"Vet Immunol Immunopathol"},{"issue":"8","key":"4366_CR28","doi-asserted-by":"publisher","first-page":"e42788","DOI":"10.1371\/journal.pone.0042788","volume":"7","author":"CG Vega","year":"2012","unstructured":"Vega CG, Bok M, Vlasova AN, Chattha KS, Fern\u00e1ndez FM, Wigdorovitz A, et al. IgY antibodies protect against human rotavirus induced diarrhea in the neonatal gnotobiotic piglet disease model. PLoS ONE. 2012;7(8):e42788. https:\/\/doi.org\/10.1371\/journal.pone.0042788.","journal-title":"PLoS ONE"},{"issue":"2","key":"4366_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/026119290503300208","volume":"33","author":"R Schade","year":"2005","unstructured":"Schade R, Calzado EG, Sarmiento R, Chacana PA, Porankiewicz-Asplund J, Terzolo HR. Chicken egg yolk antibodies (IgY-technology): a review of progress in production and use in research and human and veterinary medicine. Altern Lab Anim. 2005;33(2):129\u201354. https:\/\/doi.org\/10.1177\/026119290503300208.","journal-title":"Altern Lab Anim"},{"key":"4366_CR30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.intimp.2019.05.015","volume":"73","author":"EP Pereira","year":"2019","unstructured":"Pereira EP, van Tilburg MF, Florean EO, Guedes MI. Egg yolk antibodies (IgY) and their applications in human and veterinary health: a review. Int Immunopharmacol. 2019;73:293\u2013303. https:\/\/doi.org\/10.1016\/j.intimp.2019.05.015.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"4366_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0147-9571(90)90088-B","volume":"13","author":"A Larsson","year":"1990","unstructured":"Larsson A, Sj\u00f6quist J. Chicken IgY: utilizing the evolutionary difference. Comp Immunol Microbiol Infect Dis. 1990;13(4):199\u2013201. https:\/\/doi.org\/10.1016\/0147-9571(90)90088-B.","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"1","key":"4366_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s007050170195","volume":"146","author":"A Di Lonardo","year":"2001","unstructured":"Di Lonardo A, Marcante ML, Poggiali F, Hamsikova E, Venuti A. Egg yolk antibodies against the E7 oncogenic protein of human papillomavirus type 16. Arch Virol. 2001;146(1):117\u201325. https:\/\/doi.org\/10.1007\/s007050170195.","journal-title":"Arch Virol"},{"issue":"4","key":"4366_CR33","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/jpm12040594","volume":"12","author":"C Cheng","year":"2022","unstructured":"Cheng C, Ou B, Lung F. Developing a biosensor-based immunoassay to detect HPV E6 oncoprotein in the saliva rinse fluid of oral cancer patients. J Pers Med. 2022;12(4):594. https:\/\/doi.org\/10.3390\/jpm12040594.","journal-title":"J Pers Med"},{"key":"4366_CR34","doi-asserted-by":"publisher","first-page":"645559","DOI":"10.3389\/fmed.2021.645559","volume":"8","author":"A Major","year":"2021","unstructured":"Major A, Sk\u0159iv\u00e1nek A, Grandjean E, Dvo\u0159\u00e1k V, Mal\u00edk T, Pluta M, et al. An adsorptive and antioxidant vaginal gel clears high-risk HPV- and p16\/Ki-67-associated abnormal cytological cervical findings: a post-hoc subgroup analysis of a prospective randomized controlled trial on CIN2 and p16 positive CIN1. Front Med (Lausanne). 2021;8:645559. https:\/\/doi.org\/10.3389\/fmed.2021.645559.","journal-title":"Front Med (Lausanne)"},{"key":"4366_CR35","doi-asserted-by":"publisher","first-page":"1047222","DOI":"10.3389\/fonc.2022.1047222","volume":"12","author":"S Zhou","year":"2022","unstructured":"Zhou S, Wu D, Yao H, Zhang W, Tian F, Chen G, et al. REBACIN\u00ae inhibits E6\/E7 oncogenes in clearance of human papillomavirus infection. Front Oncol. 2022;12:1047222. https:\/\/doi.org\/10.3389\/fonc.2022.1047222.","journal-title":"Front Oncol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-026-04366-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04366-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04366-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T01:30:08Z","timestamp":1781487008000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12905-026-04366-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4366"],"URL":"https:\/\/doi.org\/10.1186\/s12905-026-04366-6","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"26 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This prospective observational study was approved by the Ethics Committee of the First Affiliated Hospital of Sun Yat-Sen University (Institutional Review Board (IRB) number 2022\u2009\u2212\u2009115), and adhered to the principles of the Helsinki Declaration as well as national and international standards. The patients provided written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"299"}}